Sublethal concentrations of Au (III), Pd (II), and Ni(II) differentially alter inflammatory cytokine secretion from activated monocytes
- 17 December 2003
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 69B (1) , 11-17
- https://doi.org/10.1002/jbm.b.20029
Abstract
Many transition metals have been viewed collectively as nonspecific biological toxins in cells, which has limited investigation into their possible therapeutic effects. In the current study, the effects of Au(III), Ni(II), and Pd(II) on the differential secretion of cytokines from monocytes has been investigated. This is critical to understanding any therapeutic potential of these metals, their allergenicity, or the clinical effects of current metal therapies such as chrysotherapy. Lethal concentrations (defined as > 50% suppression of mitochondrial succinate dehydrogenase (SDH) activity) of metals were determined by dose-response curves with the use of 72 h exposures to human THP-1 monocytes. Then, secretion of TNFα, IL1β, and IL6 were measured after the monocytes were exposed to sublethal concentrations of metals, with or without stimulation by lipopolysaccharide. The concentrations of Au(III), Pd(II), and Ni(II) required to suppress SDH activity by 50% were found to be 255, 270, and 90 μM, respectively. No sublethal concentration of any metal alone caused secretion of the cytokines. However, LPS-induced cytokine secretion was significantly and differentially altered by sublethal concentrations of each metal. Differential responses were highly dependent on metal concentration and involved both suppression and potentiation of the LPS activation. In the case of Ni(II), potentiation of TNFα, IL1β, and IL6 ranged from 200% for TNFα to over 1200% for IL6. Metals such as Au(III), Pd(II), and Ni(II) differentially alter cytokine expression from monocytes. These results imply that metals have more specific effects on cell signaling than previously assumed. These results also are important in explaining multiple clinical effects often seen with chrysotherapy, identifying potential new avenues for metal therapy, and understanding the inflammatory effects of metals such as nickel. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 69B: 11–17, 2004Keywords
This publication has 24 references indexed in Scilit:
- Effect of subtoxic concentrations of metal ions on NFκB activation in THP‐1 human monocytesJournal of Biomedical Materials Research Part A, 2002
- Human monocyte/macrophage response to cobalt‐chromium corrosion products and titanium particles in patients with total joint replacementsJournal of Orthopaedic Research, 1997
- Response of L-929 Fibroblasts, Human Gingival Fibroblasts, and Human Tissue Mast Cells to Various Metal CationsJournal of Dental Research, 1995
- Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitroFEBS Letters, 1995
- The role of inflammatory mediators in the pathogenesis of periodontal diseaseJournal of Periodontal Research, 1991
- Nickel, chromium, cobalt dental alloys and allergic reactions: an overviewBiomaterials, 1989
- Systemic effects of biomaterialsBiomaterials, 1984
- Biomaterial biocompatibility and the macrophageBiomaterials, 1984
- Serum concentrations of chromium, cobalt and nickel after total hip replacement: a six month studyBiomaterials, 1983
- Cytotoxicity to alveolar macrophages of trace metals adsorbed on fly ashEnvironmental Research, 1979